Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 1,301 shares at $4.49 ($6K) on 2023-02-21, disclosed to the SEC on 2023-02-23.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.49 | 228 | $1K | 17.6% |
| 2 | $4.48 | 1,073 | $5K | 82.4% |
| Total | $4.48 avg | 1,301 | $6K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |